stockpiling tirzepatide Glapp Introduces Smart Vial Tracking for Compounded Eli Lilly to seek approval

Observational studies did not find a significant difference in lupus risk between GLP-1 receptor agonist users and non-users

Directions for use: Give 1 chew per 30 lbs of body weight daily

(AP) What to expect when starting a GLP-1 Patients who start GLP-1s for weight loss may first notice they feel more full after eating and think less about food, sometimes called food noise. Nausea, vomiting, bloating, diarrhea and constipation are normal in these first few days and after a dosage increase

People who take the most common categories of weight-loss drugs, semaglutide and tirzepatide, marketed as Ozempic, Wegovy and Zepbound, tended to lose about 33 pounds during their treatment but then regained about 22 pounds in the first year after stopping, Sam West, a physiology researcher at Oxford University who co-wrote the study, said in a phone interview Thursday